Aptose Biosciences (APTO) said Friday that it plans to sell 40 million shares and 20 million warrants worth $8 million in a public offering.
The offering is expected to be completed on Monday, the company said.
Net proceeds will be used for working capital and general corporate purposes, the company said.
Aptose Biosciences' shares were down nearly 45% in recent trading.
Price: 0.13, Change: -0.11, Percent Change: -45.90
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.